Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from the largest prospective, multicenter study to date ...
Combination of Castle Biosciences’ DecisionDx-UM and PRAME show predicting outcomes in patients with uveal melanoma: Study: Friendswood, Texas Friday, December 19, 2025, 15:00 H ...
Rb1 loss may serve as a predictive biomarker to guide new targeted therapies for select breast cancers resistant to standard ...
BillionToOne saw rapid growth in molecular diagnostics, strong Q3 results, and evolving valuation. Read here for more ...
Morning Overview on MSN
Android’s Bluetooth car audio bug has lingered for over a year
Android’s promise in the car is simple: you step in, the phone pairs, music and navigation flow through the speakers, and you ...
Whether a leader is allocating capital, hiring or planning for supply-chain risk, AI’s advantage isn’t foresight—it’s ...
After many folks dug themselves out of the snow Christmas Eve morning, some more light snow accumulations are on the way for ...
AI writing tools are supercharging scientific productivity, with researchers posting up to 50% more papers after adopting ...
Interesting Engineering on MSN
AI advisor keeps scientists in the loop while supercharging self-driving lab results
The research introduces an “AI advisor” model designed to guide, not dominate, autonomous labs. Instead of locking ...
In at least four communities, Casella put off Wednesday's collection until next Wednesday. That goes for Auburn, South ...
The study shows that failures in public-sector AI adoption are often rooted in organizational design rather than ...
A rise in reports of psychosis-like symptoms is increasing pressure on companies and policymakers to address the potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback